GGrantIndex
Sort

39,280 grants matching leukemia

State-transition and leukemia potential dynamics to inform disease evolution and adaptive therapy

$590,960
Russell Christian Rockne · Beckman Research Institute/City Of Hope · U01 · FY2025 · CA

Designing T cells to Functionally Cure HIV-1 infection

$590,667
James L Riley · University Of Pennsylvania · U19 · FY2017 · AI

Targeting IRE-1a/XBP-1 Axis for Control of Chronic GVHD and Leukemia Relapse

$590,612
Xue-Zhong Yu · Medical University Of South Carolina · R01 · FY2019 · HL

Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds

$590,577
Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2017 · CA

Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds

$590,577
Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2020 · CA

Genomic Architecture of LGL Leukemia

$590,474
Thomas P Loughran · University Of Virginia · R01 · FY2019 · CA

Chromatin mobility in response to DNA damage

$590,454
Pierre-Alexandre Vidi · Wake Forest University Health Sciences · U01 · FY2020 · CA

Studies of other risk factors for radiosensitive tumors

$590,334
Amy Berrington · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

Mechanisms of Silencing of Retroviral DNAs in Embryonic Cell Lines

$590,302
Stephen P Goff · Columbia University Health Sciences · R01 · FY2023 · CA

Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency

$590,272
Dennis Hickstein · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA

Lentiviral Gene Therapy and Genome Editing for X-linked Severe Combined Immunodeficiency

$590,189
Stephen Gottschalk · St. Jude Children'S Research Hospital · P01 · FY2018 · HL

PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)

$590,109
William E. Evans · St. Jude Children'S Research Hospital · R37 · FY2009 · CA

MALDI-TOF/TOF MS TO SUPPORT BIOMEDICAL RESEARCH

$590,018
Catherine E. Costello · Boston University Medical Campus · S10 · FY2012 · OD

Genomics of Megakaryocyte and Platelet Biology

$589,972
Jorge A Dipaola · Washington University · R01 · FY2020 · HL

XBP1 Inhibition and STING activation for the treatment of cancer

$589,861
Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2022 · CA

Proteasome/HDAC Inhibition in Leukemia/MDS; Phase I Trial and Correlative Studies

$589,802
Steven Grant · Virginia Commonwealth University · RC2 · FY2010 · CA

Development of novel selective Rac inhibitors for refractory leukemias

$589,782
David A Williams · Boston Children'S Hospital · R01 · FY2019 · CA

AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis

$589,759
John Hackett Bushweller · University Of Virginia · R01 · FY2023 · CA

AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis

$589,759
John Hackett Bushweller · University Of Virginia · R01 · FY2022 · CA

Semantic Data Lake for Biomedical Research

$589,741
Mansur R. Kabuka · Infotech Soft, Inc. · R44 · FY2017 · CA

Apolipoprotein M: a novel regulator of myocardial Autophagy

$589,712
Ali Javaheri · Washington University · R01 · FY2025 · HL

Nuclear Medicine Core

$589,695
Joseph G Rajendran · Fred Hutchinson Cancer Research Center · P01 · FY2013 · CA

Targeting Notch2 in Hematopoietic Cell Therapy.

$589,683
Lan Zhou · Case Western Reserve University · R01 · FY2019 · HL

Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1

$589,340
Christopher Y Park · New York University School Of Medicine · R01 · FY2022 · CA

Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1

$589,340
Christopher Y Park · New York University School Of Medicine · R01 · FY2023 · CA